Sofinnova Partners
Sofinnova Partners is one of the leading European venture capital firms dedicated exclusively to life sciences. With over 50 years of experience, the firm invests across therapeutics, medical devices, diagnostics, and digital health, and has backed numerous successful companies that have transformed patient care.
Location
Paris, France
Founded
1972
AUM
€3B+
Investment Range
€5M - €50M
Portfolio Companies
23
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth
Investment Thesis
Sofinnova Partners invests in innovative life sciences companies across Europe and globally. They focus on companies developing breakthrough therapies, medical technologies, and digital health solutions with strong scientific foundations and clear paths to clinical development. Their experienced team brings deep scientific expertise and extensive industry networks to support portfolio companies.
Team
Partners / Managing Directors
- Antoine Papiernik - Managing Partner
- Graziano Seghezzi - Managing Partner
- Maha Katabi, PhD - General Partner
- Joanna Horobin, MB ChB - Partner
Other Key Team Members
- Michael Krel - Partner
- Rafaèle Tordjman, MD, PhD - Founder of Jeito Capital (former Sofinnova Partner)
Focus Areas
- Oncology
- Immunology
- Rare Diseases
- Neurology
- Gene & Cell Therapy
- Medical Devices
- Digital Health
- Diagnostics
Notable Portfolio Companies
- Kymera Therapeutics - Targeted protein degradation (IPO 2020)
- Compass Pathways - Psilocybin therapy for depression (IPO 2020)
- Aprea Therapeutics - p53-targeting cancer therapy (IPO 2019)
- Imcheck Therapeutics - Cancer immunotherapy
- Owkin - AI for drug discovery
Notable Exits
- Kymera Therapeutics - IPO (2020, NASDAQ: KYMR)
- Compass Pathways - IPO (2020, NASDAQ: CMPS)
- Aprea Therapeutics - IPO (2019, NASDAQ: APRE)
- Cellectis - IPO (2015, NASDAQ: CLLS)
- GenSight Biologics - IPO (Euronext: SIGHT)
- DBV Technologies - IPO (NASDAQ: DBVT)
Sources
- Sofinnova Partners website: https://sofinnovapartners.com
- https://sofinnovapartners.com/team
- Crunchbase: https://www.crunchbase.com/organization/sofinnova-partners
- European Venture Capital Association
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Enthera Pharmaceuticals | Milan, Italy | 2016 | biotechautoimmune+3 |
| ENYO Pharma | Lyon, France | 2014 | biotechtherapeutics+3 |
| Delinia | Watertown, Massachusetts, USA | 2020 | biotechautoimmune+3 |
| DISCO Pharmaceutical | - | - | biotechpharmaceuticals+1 |
| CinCor Pharma | Waltham, Massachusetts, USA | 2018 | biotechpharmaceuticals+3 |
| Corvidia Therapeutics | Waltham, Massachusetts, USA | 2015 | biotechcardiovascular+3 |
| CorWave | Clichy, France | 2012 | medical-devicescardiovascular+3 |
| Crescendo Biologics | Cambridge, United Kingdom | 2009 | biotechimmuno-oncology+3 |
| Cure51 | Paris, France | 2021 | digital-medicineai+3 |
| DBV Technologies | Bagneux, France | 2002 | biotechallergy+3 |
| deepc | Munich, Germany | 2017 | digital-medicineai+3 |
| Elevara Medicine | - | - | biotechautoimmune+3 |
| Endoron Medical | Israel | - | medical-devicesvascular+2 |
| EnginZyme | Stockholm, Sweden | 2014 | industrial-biotechenzymes+3 |
| DNA Script | Paris, France & San Francisco, California, USA | 2014 | biotechdna-synthesis+3 |
| Hemab Therapeutics | Copenhagen, Denmark | 2020 | biotechhematology+2 |
| MISSION Therapeutics | Cambridge, United Kingdom | 2011 | biotechmitochondria+3 |
| NanoPhoria | Paris, France | 2021 | biotechdrug-delivery+3 |
| One Biosciences | Bengaluru, India | 2020 | biotechsingle-cell+2 |
| Arzeda Corporation | Seattle, Washington, USA | 2008 | biotechprotein-design+3 |
| Kiro | Paris, France | 2020 | digital-medicineai+3 |
| BioCorteX | Munich, Germany | 2018 | digital-medicineai+3 |
| Betteromics | Paris, France | 2019 | digital-medicinedata-platform+3 |